Attempts to hoist separate statehood flag during Rajyotsava foiled

Benglauru, June 14: Even as schools are divided over providing online education, the state Higher Education Department is stressing on continuing online education.

Deputy Chief Minister and Higher Education Minister Dr C N Ashwath Narayan has stressed the need for digital learning to eliminate educational inequalities.

Taking part in a Webinar on ‘Digitising Higher Education - Challenges and Opportunities,’ organised by the Padmashree Institute of Management, he asked educational institutions to give emphasis to digital learning.

“Digital learning is a means to ensure quality education to all sections of the society without discrimination on the basis of caste, region and religion. This is a solution to eliminate discrimination. Through digital learning, a student in a remote village will also get an opportunity to learn from an experienced and highly qualified teacher.”

In addition to this, students are getting study material in digital form. Keeping these important aspects in mind, all educational institutions should give stress to digital learning without wasting any time,’’ he said.

He, however, admitted that digital learning has its own challenges like - quality internet connectivity, laptops and mobile gadgets.

“We are trying to find a solution to it by raising funds through Corporate Social Responsibility or through government funds,” he said. “We are making efforts to provide 4G network across the State,” he said.

Mumbai, Jun 14: Bollywood actor Sushant Singh Rajput committed suicide on Sunday, leaving all his fans and the industry in shock. While the reason behind him taking up the extreme step is still not clear, a look into Sushant’s social media feed suggests that things were not well for him for quite some time.

Sushant had been inactive on Twitter since months. His last tweet was on December 27, 2019. Since then, he did not even reply to any one on Twitter. Same is the case with his Facebook account as the last post on his timeline was on the same date. Interestingly, Sushant's Twitter cover picture is the popular painting - 'Starry Night', by Van Gogh, who had also reportedly committed suicide in 1890.

On Instagram, the young actor had last posted on June 3. It was a collage picture of him and his mother along with a cryptic caption that read, “Blurred past evaporating from teardrops Unending dreams carving an arc of smile And a fleeting life, negotiating between the two...#माँ”.

Was Sushant’s inactivity on Twitter, Facebook and his last cryptic post on Instagram a signal that the actor was having a tough time? Well, may be it will remain a mystery forever.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.